SEC Form 4 · accession 0001140361-15-035895
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine J Heron
Director
Period of report
Sep 8, 2015
Accepted (ET)
Sep 25, 2015 · 12:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2015 | M | 15,000 | $21.51 | A | 35,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2,F1 | $21.51 | Sep 8, 2015 | M | 15,000 | D | Nov 12, 2010 | May 11, 2020 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Stock option grant vests 6/48ths on November 12, 2010, and 1/48th on the 12th day of every month thereafter.
- F2Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.